Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Fintepla® (fenfluramine) – New orphan drug approval
June 25, 2020 - The FDA announced the approval of Zogenix’s Fintepla (fenfluramine), for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
